Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Torres

Showing results (1101-1110 of 1,246) with videos related to

Pageof 125
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2011
Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumorsKeila E Torres, Quan-Sheng Zhu, Katelynn Bill, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2010
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney diseaseVicente E Torres, Jared J Grantham, Arlene B Chapman, et al.
The New Phytologist|October 27, 2022
A highly polymorphic effector protein promotes fungal virulence through suppression of plant-associated ActinobacteriaNick C Snelders, Jordi C Boshoven, Yin Song, et al.
Physical Chemistry Chemical Physics : PCCP|October 19, 2023
Ion specific tuning of nanoparticle dispersion in an ionic liquid: a structural, thermoelectric and thermo-diffusive investigationT Fiuza, M Sarkar, J C Riedl, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical TrialMarie C Hogan, Julie A Chamberlin, Lisa E Vaughan, et al.
American Journal of Surgery|December 18, 2019
Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resectionEmily Z Keung, Elliot A Asare, Yi-Ju Chiang, et al.
Royal Society Open Science|April 8, 2020
Correction to '<i>ALOX5, LPA, MMP9</i> and <i>TPO</i> gene polymorphisms increase atherothrombosis susceptibility in middle-aged Mexicans'Rafael Camacho-Mejorado, Rocío Gómez, Luisa E Torres-Sánchez, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 21, 2018
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney DiseaseMarie E Edwards, Fouad T Chebib, Maria V Irazabal, et al.
Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.
Annals of the New York Academy of Sciences|September 29, 2011
Barrett's esophagus: endoscopic treatments IMichael D Saunders, Alejandro Nieponice, Katerina Dvorak, et al.
Pageof 125

Showing results (1101-1110 of 1,246) with videos related to

Sort By:
Pageof 125
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2011
Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumorsKeila E Torres, Quan-Sheng Zhu, Katelynn Bill, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2010
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney diseaseVicente E Torres, Jared J Grantham, Arlene B Chapman, et al.
The New Phytologist|October 27, 2022
A highly polymorphic effector protein promotes fungal virulence through suppression of plant-associated ActinobacteriaNick C Snelders, Jordi C Boshoven, Yin Song, et al.
Physical Chemistry Chemical Physics : PCCP|October 19, 2023
Ion specific tuning of nanoparticle dispersion in an ionic liquid: a structural, thermoelectric and thermo-diffusive investigationT Fiuza, M Sarkar, J C Riedl, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical TrialMarie C Hogan, Julie A Chamberlin, Lisa E Vaughan, et al.
American Journal of Surgery|December 18, 2019
Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resectionEmily Z Keung, Elliot A Asare, Yi-Ju Chiang, et al.
Royal Society Open Science|April 8, 2020
Correction to '<i>ALOX5, LPA, MMP9</i> and <i>TPO</i> gene polymorphisms increase atherothrombosis susceptibility in middle-aged Mexicans'Rafael Camacho-Mejorado, Rocío Gómez, Luisa E Torres-Sánchez, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 21, 2018
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney DiseaseMarie E Edwards, Fouad T Chebib, Maria V Irazabal, et al.
Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.
Annals of the New York Academy of Sciences|September 29, 2011
Barrett's esophagus: endoscopic treatments IMichael D Saunders, Alejandro Nieponice, Katerina Dvorak, et al.
Pageof 125